The Negative HIV Test That Wasn't Negative
A 29-year-old man presents with a 3-week history of fever, sore throat, rash, and generalised lymphadenopathy after a high-risk exposure 4 weeks ago. The laboratory performs a 4th-generation HIV antigen/antibody combination immunoassay (CMIA) on serum. The result is reactive (signal/cutoff 3.2). The laboratory's algorithm then runs a supplementary differentiation immunoassay, which is negative. A HIV-1 RNA qualitative assay is requested but the sample volume is insufficient for the viral load platform. The clinician calls asking whether the patient has HIV and whether to start antiretroviral therapy. The patient is anxious and has asked for a definitive answer today.
1. Interpret the combination of a reactive 4th-generation screen with a negative differentiation assay in this clinical context. What are the possible explanations?
Read the worked answer
Reactive screen + negative differentiation assay is an indeterminate pattern that requires resolution. Possibilities:
- Early/acute HIV infection - the 4th-generation assay detects p24 antigen before antibodies mature. A reactive screen with a negative antibody differentiation assay is the classic signature of acute HIV, especially with a compatible 4-week exposure history and seroconversion illness. This is the most important diagnosis to exclude.
- False-positive screen - CMIA false positives occur (e.g., recent vaccination, autoimmune disease, pregnancy, other infections). The signal/cutoff of 3.2 is moderately reactive, not strongly reactive.
- Cross-reacting antibodies to other agents.
Conclusion: the pattern is not 'HIV negative'. It is indeterminate and, given the exposure and symptoms, acute HIV must be assumed until excluded. The algorithm requires a HIV-1 RNA test (or repeat serology in 2–4 weeks) to resolve.
2. The sample volume is insufficient for RNA testing. What are your options and how would you prioritise them?
Read the worked answer
Options, in priority order:
- Obtain a fresh sample - a dedicated EDTA plasma tube for HIV-1 RNA. This is the definitive test and should be the first action; contact the clinic to arrange urgent re-draw.
- Repeat the combination assay on a new sample - if it remains reactive, supports true reactivity; if it becomes negative, suggests a transient false positive (but does not exclude very early infection).
- Repeat serology in 2–4 weeks - for seroconversion; useful but slower.
Do not rely on the negative differentiation assay to declare the patient uninfected. Do not delay counselling.
Practical steps:
- Phone the clinician, explain the indeterminate result and the need for a fresh EDTA sample for RNA.
- Arrange same-day re-draw and expedite the RNA test.
- Document the insufficient-volume problem as a pre-analytical issue and request adequate volume on future requests.
3. What counselling and infection-control advice should be given while the result is pending?
Read the worked answer
Counselling:
- Explain honestly that the result is indeterminate, not negative; a definitive answer requires an additional test.
- Advise safer sex / avoidance of unprotected intercourse and needle sharing until resolved.
- Discuss the possibility of acute HIV and the importance of early treatment if confirmed (treatment as prevention and improved outcomes).
- Offer psychological support and confidentiality assurances.
Infection control / public health:
- Advise the patient not to donate blood, organs, or semen.
- Partner notification should be discussed if infection is confirmed.
- If acute HIV is confirmed, link to care promptly; ART is now recommended for all confirmed HIV regardless of CD4.
Do not start ART on an indeterminate result alone; confirm first, but arrange urgent follow-up so treatment is not delayed if positive.